These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 35264596)
1. Detection of germline variants in Brazilian breast cancer patients using multigene panel testing. Guindalini RSC; Viana DV; Kitajima JPFW; Rocha VM; López RVM; Zheng Y; Freitas É; Monteiro FPM; Valim A; Schlesinger D; Kok F; Olopade OI; Folgueira MAAK Sci Rep; 2022 Mar; 12(1):4190. PubMed ID: 35264596 [TBL] [Abstract][Full Text] [Related]
2. Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls. Akcay IM; Celik E; Agaoglu NB; Alkurt G; Kizilboga Akgun T; Yildiz J; Enc F; Kir G; Canbek S; Kilic A; Zemheri E; Ezberci F; Ozcelik M; Dinler Doganay G; Doganay L Int J Cancer; 2021 Jan; 148(2):285-295. PubMed ID: 32658311 [TBL] [Abstract][Full Text] [Related]
3. Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis. Sandoval RL; Leite ACR; Barbalho DM; Assad DX; Barroso R; Polidorio N; Dos Anjos CH; de Miranda AD; Ferreira ACSM; Fernandes GDS; Achatz MI PLoS One; 2021; 16(2):e0247363. PubMed ID: 33606809 [TBL] [Abstract][Full Text] [Related]
4. Germline variants of Brazilian women with breast cancer and detection of a novel pathogenic ATM deletion in early-onset breast cancer. Bandeira G; Rocha K; Lazar M; Ezquina S; Yamamoto G; Varela M; Takahashi V; Aguena M; Gollop T; Zatz M; Passos-Bueno MR; Krepischi A; Okamoto OK Breast Cancer; 2021 Mar; 28(2):346-354. PubMed ID: 32986223 [TBL] [Abstract][Full Text] [Related]
5. Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. Hauke J; Horvath J; Groß E; Gehrig A; Honisch E; Hackmann K; Schmidt G; Arnold N; Faust U; Sutter C; Hentschel J; Wang-Gohrke S; Smogavec M; Weber BHF; Weber-Lassalle N; Weber-Lassalle K; Borde J; Ernst C; Altmüller J; Volk AE; Thiele H; Hübbel V; Nürnberg P; Keupp K; Versmold B; Pohl E; Kubisch C; Grill S; Paul V; Herold N; Lichey N; Rhiem K; Ditsch N; Ruckert C; Wappenschmidt B; Auber B; Rump A; Niederacher D; Haaf T; Ramser J; Dworniczak B; Engel C; Meindl A; Schmutzler RK; Hahnen E Cancer Med; 2018 Apr; 7(4):1349-1358. PubMed ID: 29522266 [TBL] [Abstract][Full Text] [Related]
6. The genetics of hereditary cancer risk syndromes in Brazil: a comprehensive analysis of 1682 patients. de Oliveira JM; Zurro NB; Coelho AVC; Caraciolo MP; de Alexandre RB; Cervato MC; Minillo RM; de Vasconcelos Carvalho Neto G; Grivicich I; Oliveira JB Eur J Hum Genet; 2022 Jul; 30(7):818-823. PubMed ID: 35534704 [TBL] [Abstract][Full Text] [Related]
7. Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients. Paixão D; Torrezan GT; Santiago KM; Formiga MN; Ahuno ST; Dias-Neto E; Tojal da Silva I; Foulkes WD; Polak P; Carraro DM Front Oncol; 2022; 12():976959. PubMed ID: 36119527 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of germline variants in consensus moderate-to-high-risk predisposition genes to hereditary breast and ovarian cancer in BRCA1/2-negative Brazilian patients. Gomes R; Spinola PDS; Brant AC; Matta BP; Nascimento CM; de Aquino Paes SM; Bonvicino CR; Dos Santos ACE; Moreira MAM Breast Cancer Res Treat; 2021 Feb; 185(3):851-861. PubMed ID: 33128190 [TBL] [Abstract][Full Text] [Related]
9. Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer. Ryu JS; Lee HY; Cho EH; Yoon KA; Kim MK; Joo J; Lee ES; Kang HS; Lee S; Lee DO; Lim MC; Kong SY Cancer Sci; 2020 Oct; 111(10):3912-3925. PubMed ID: 32761968 [TBL] [Abstract][Full Text] [Related]
11. Germline mutations of breast cancer susceptibility genes through expanded genetic analysis in unselected Colombian patients. Sierra-Díaz DC; Morel A; Fonseca-Mendoza DJ; Bravo NC; Molano-Gonzalez N; Borras M; Munevar I; Lema M; Idrobo H; Trujillo D; Serrano N; Orduz AI; Lopera D; González J; Rojas G; Londono-De Los Ríos P; Manneh R; Cabrera R; Rubiano W; de la Peña J; Quintero MC; Mantilla W; Restrepo CM Hum Genomics; 2024 Jun; 18(1):68. PubMed ID: 38890714 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer in East Africa: Prevalence and spectrum of germline SNV/indel and CNVs in BRCA1 and BRCA2 genes among breast cancer patients in Tanzania. Rweyemamu LP; Gültaşlar BK; Akan G; Dharsee N; Namkinga LA; Lyantagaye SL; Yazıcı H; Atalar F Cancer Med; 2023 Feb; 12(3):3395-3409. PubMed ID: 35908255 [TBL] [Abstract][Full Text] [Related]
13. Frequency of germline genetic variants in women with a personal or family history of breast cancer from Brazil. Pereira JZ; Carneiro JG; Vieira MS; Valente BM; de Oliveira PZ; Mello CL; de Campos CLV; Gomes KB Mol Biol Rep; 2022 Oct; 49(10):9509-9520. PubMed ID: 35980532 [TBL] [Abstract][Full Text] [Related]
14. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer. Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626 [TBL] [Abstract][Full Text] [Related]
15. Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients. Rodríguez-Balada M; Roig B; Melé M; Albacar C; Serrano S; Salvat M; Querol M; Borràs J; Martorell L; Gumà J Clin Biochem; 2020 Feb; 76():17-23. PubMed ID: 31786208 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil. Cotrim DP; Ribeiro ARG; Paixão D; de Queiroz Soares DC; Jbili R; Pandolfi NC; Cezana C; de Cássia Mauro C; Mantoan H; Bovolim G; de Brot L; Torrezan GT; Carraro DM; Baiocchi G; da Cruz Formiga MN; da Costa AABA BMC Cancer; 2019 Jan; 19(1):4. PubMed ID: 30606148 [TBL] [Abstract][Full Text] [Related]
17. Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing. Giri VN; Hartman R; Pritzlaff M; Horton C; Keith SW JCO Precis Oncol; 2022 May; 6(1):e2200234. PubMed ID: 35666082 [TBL] [Abstract][Full Text] [Related]
18. Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study. Nassar A; Zekri AN; Kamel MM; Elberry MH; Lotfy MM; Seadawy MG; Hassan ZK; Soliman HK; Lymona AM; Youssef ASE Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672847 [TBL] [Abstract][Full Text] [Related]
19. What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database. Ni M; Wang F; Yang A; Shao Q; Xue C; Xia W; Xu F; Lin X; Huang J; Bi X; Hong R; Chen M; Zheng Q; Jiang K; Xie X; Tang J; Wang X; Yuan Z; Wang S; Shi Y; An X Cancer Med; 2023 Jun; 12(12):13019-13030. PubMed ID: 37096751 [TBL] [Abstract][Full Text] [Related]
20. Germline variants of uncertain significance, their frequency, and clinico-pathological features in a cohort of Sri Lankan patients with hereditary breast cancer. Gunawardena K; Sirisena ND; Anandagoda G; Neththikumara N; Dissanayake VHW BMC Res Notes; 2023 Jun; 16(1):95. PubMed ID: 37277882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]